Your browser doesn't support javascript.
loading
Resolving distinct molecular origins for copper effects on PAI-1.
Bucci, Joel C; McClintock, Carlee S; Chu, Yuzhuo; Ware, Gregory L; McConnell, Kayla D; Emerson, Joseph P; Peterson, Cynthia B.
Afiliación
  • Bucci JC; Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Walters Life Sciences Building, 1414 Cumberland Avenue, Knoxville, TN, 37996, USA.
  • McClintock CS; Department of Biological Sciences, A221 Life Sciences Annex, Louisiana State University, Baton Rouge, LA, 70803, USA.
  • Chu Y; Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Walters Life Sciences Building, 1414 Cumberland Avenue, Knoxville, TN, 37996, USA.
  • Ware GL; Department of Biological Sciences, A221 Life Sciences Annex, Louisiana State University, Baton Rouge, LA, 70803, USA.
  • McConnell KD; Department of Biological Sciences, A221 Life Sciences Annex, Louisiana State University, Baton Rouge, LA, 70803, USA.
  • Emerson JP; Department of Chemistry, Mississippi State University, Box 1115, Starkville, MS, 39762, USA.
  • Peterson CB; Department of Chemistry, Mississippi State University, Box 1115, Starkville, MS, 39762, USA.
J Biol Inorg Chem ; 22(7): 1123-1135, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28913669
ABSTRACT
Components of the fibrinolytic system are subjected to stringent control to maintain proper hemostasis. Central to this regulation is the serpin plasminogen activator inhibitor-1 (PAI-1), which is responsible for specific and rapid inhibition of fibrinolytic proteases. Active PAI-1 is inherently unstable and readily converts to a latent, inactive form. The binding of vitronectin and other ligands influences stability of active PAI-1. Our laboratory recently observed reciprocal effects on the stability of active PAI-1 in the presence of transition metals, such as copper, depending on the whether vitronectin was also present (Thompson et al. Protein Sci 20353-365, 2011). To better understand the molecular basis for these copper effects on PAI-1, we have developed a gel-based copper sensitivity assay that can be used to assess the copper concentrations that accelerate the conversion of active PAI-1 to a latent form. The copper sensitivity of wild-type PAI-1 was compared with variants lacking N-terminal histidine residues hypothesized to be involved in copper binding. In these PAI-1 variants, we observed significant differences in copper sensitivity, and these data were corroborated by latency conversion kinetics and thermodynamics of copper binding by isothermal titration calorimetry. These studies identified a copper-binding site involving histidines at positions 2 and 3 that confers a remarkable stabilization of PAI-1 beyond what is observed with vitronectin alone. A second site, independent from the two histidines, binds metal and increases the rate of the latency conversion.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidor 1 de Activador Plasminogénico / Cobre Límite: Humans Idioma: En Revista: J Biol Inorg Chem Asunto de la revista: BIOQUIMICA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidor 1 de Activador Plasminogénico / Cobre Límite: Humans Idioma: En Revista: J Biol Inorg Chem Asunto de la revista: BIOQUIMICA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos